Modulation of host innate and adaptive immune defenses by cytomegalovirus: Timing is everything: Symposium

Journal of Internal Medicine

Volumn 267, Issue 5, 2010, Pages 483-501

  Loewendorf, A ^a   Benedict, C A ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Cytokines; Herpes virus; Immunity; Immunology; Infectious disease; Virology

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PERFORIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; BIRTH DEFECT; CELL ACTIVATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; EVOLUTION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; INFECTION RESISTANCE; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN INDUCTION; SPECIES DIFFERENCE; T LYMPHOCYTE; TISSUE SPECIFICITY; VIRUS CELL INTERACTION; VIRUS INDUCTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; INTERFERONS; MICE; NF-KAPPA B; SPLEEN; T-LYMPHOCYTES; TIME FACTORS; VIRAL LOAD;

EID: 77950469982     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02220.x     Document Type: Conference Paper

References (177)

1. McGeoch DJ, Dolan A, Ralph AC. Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J Virol 2000 74 : 10401 10406.
2. Pereira L, Maidji E, McDonagh S, Tabata T. Insights into viral transmission at the uterine-placental interface. Trends Microbiol 2005 13 : 164 174. (Pubitemid 40463318)
3. Redpath S, Angulo A, Gascoigne NR, Ghazal P. Immune checkpoints in viral latency. Annu Rev Microbiol 2001 55 : 531 560. (Pubitemid 32978115)
4. Jarvis M, Nelson J. Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol 2002 5 : 403.
5. Streblow DN, Dumortier J, Moses AV, Orloff SL, Nelson JA. Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol 2008 325 : 397 415.
6. Soderberg-Naucler C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 2006 259 : 219 246.
7. Cobbs CS, Harkins L, Samanta M et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002 62 : 3347 3350. (Pubitemid 34651375)
8. Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 2009 11 : 1 9.
9. Brown JM, Kaneshima H, Mocarski ES. Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis 1996 171 : 1599 1603.
10. Wang W, Taylor SL, Leisenfelder SA et al. Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice. J Virol 2005 79 : 2115 2123. (Pubitemid 40204569)
11. Murphy E, Yu D, Grimwood J et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A 2003 100 : 14976 14981. (Pubitemid 37518002)
12. Brocchieri L, Kledal TN, Karlin S, Mocarski ES. Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J Virol 2005 79 : 7570 7596. (Pubitemid 40756792)
13. Beutler B, Georgel P, Rutschmann S, Jiang Z, Croker B, Crozat K. Genetic analysis of innate resistance to mouse cytomegalovirus (MCMV). Brief Funct Genomic Proteomic 2005 4 : 203 213. (Pubitemid 43055802)
14. Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA. The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol 2007 85 : 46 54. (Pubitemid 46067321)
15. Lenac T, Arapovic J, Traven L, Krmpotic A, Jonjic S. Murine cytomegalovirus regulation of NKG2D ligands. Med Microbiol Immunol 2008 197 : 159 166.
16. DeFilippis VR. Induction and evasion of the type I interferon response by cytomegaloviruses. Adv Exp Med Biol 2007 598 : 309 324.
17. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989 320 : 1731 1735. (Pubitemid 19163129)
18. Issacs A, Lindemann J. Virus interference: the interferons. Prog Roy Soc Biol (Lond) 1957 147 : 258 273.
19. Osborn JE, Medearis DN Jr. Studies of relationship between mouse cytomegalovirus and interferon. Proc Soc Exp Biol Med 1966 121 : 819 824.
20. Oie HK, Easton JM, Ablashi DV, Baron S. Murine cytomegalovirus: induction of and sensitivity to interferon in vitro. Infect Immun 1975 12 : 1012 1017.
21. Kern ER, Olsen GA, Overall JC Jr., Glasgow LA. Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex. Antimicrob Agents Chemother 1978 13 : 344 346. (Pubitemid 8281005)
22. Grundy JE, Trapman J, Allan JE, Shellam GR, Melief CJ. Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infect Immun 1982 37 : 143 150. (Pubitemid 12095194)
23. Chong KT, Gresser I, Mims CA. Interferon as a defence mechanism in mouse cytomegalovirus infection. J Gen Virol 1983 64 (Pt 2 461 464. (Pubitemid 13115973)
24. Quinnan GV, Manischewitz JE. The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J Exp Med 1979 150 : 1549 1554.
25. Shellam GR, Allan JE, Papadimitriou JM, Bancroft GJ. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci U S A 1981 78 : 5104 5108. (Pubitemid 12229681)
26. Bukowski JF, Warner JF, Dennert G, Welsh RM. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med 1985 161 : 40 52. (Pubitemid 15169719)
27. Bukowski JF, Woda BA, Welsh RM. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol 1984 52 : 119 128. (Pubitemid 14000479)
28. Schneider K, Loewendorf A, De Trez C et al. Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 2008 3 : 67 76. (Pubitemid 351201786)
29. Banks TA, Rickert S, Benedict CA et al. A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection. J Immunol 2005 174 : 7217 7225. (Pubitemid 40705690)
30. Hsu KM, Pratt JR, Akers WJ, Achilefu SI, Yokoyama WM. Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol 2009 90 : 33 43.
31. Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995 182 : 1045 1056.
32. Orange JS, Biron CA. Characterization of early IL-12, IFN-alpha beta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 1996 156 : 4746 4756.
33. Biron CA. Initial and innate responses to viral infections - pattern setting in immunity or disease. Curr Opin Microbiol 1999 2 : 374 381.
34. Tyznik AJ, Tupin E, Nagarajan NA, Her MJ, Benedict CA, Kronenberg M. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J Immunol 2008 181 : 4452 4456.
35. Raftery MJ, Hitzler M, Winau F et al. Inhibition of CD1 antigen presentation by human cytomegalovirus. J Virol 2008 82 : 4308 4319. (Pubitemid 351563668)
36. Benedict CA, Banks TA, Senderowicz L et al. Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus detente. Immunity 2001 15 : 617 626. (Pubitemid 33016446)
37. Iversen AC, Norris PS, Ware CF, Benedict CA. Human NK cells inhibit cytomegalovirus replication through a noncytolytic mechanism involving lymphotoxin-dependent induction of IFN-beta. J Immunol 2005 175 : 7568 7574.
38. Thanos D, Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 1995 83 : 1091 1100. (Pubitemid 26007801)
39. Maniatis T, Falvo JV, Kim TH et al. Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol 1998 63 : 609 620.
40. Eickhoff J, Hanke M, Stein-Gerlach M et al. RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response. J Biol Chem 2004 279 : 9642 9652. (Pubitemid 38296033)
41. Randolph-Habecker J, Iwata M, Geballe AP, Jarrahian S, Torok-Storb B. Interleukin-1-mediated inhibition of cytomegalovirus replication is due to increased IFN-beta production. J Interferon Cytokine Res 2002 22 : 765 772. (Pubitemid 35034690)
42. Shinkura R, Kitada K, Matsuda F et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat Genet 1999 22 : 74 7. (Pubitemid 29214808)
43. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005 5 : 606 616. (Pubitemid 41113192)
44. Browne EP, Wing B, Coleman D, Shenk T. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J Virol 2001 75 : 12319 12330. (Pubitemid 33115904)
45. Taylor RT, Bresnahan WA. Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production. J Virol 2005 79 : 3873 3877.
46. Taylor RT, Bresnahan WA. Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression. J Virol 2006 80 : 920 928.
47. Montag C, Wagner J, Gruska I, Hagemeier C. Human cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1beta-mediated NF-kappaB signaling. J Virol 2006 80 : 11686 11698. (Pubitemid 44788882)
48. Jarvis MA, Borton JA, Keech AM et al. Human cytomegalovirus attenuates interleukin-1beta and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-kappaB activation. J Virol 2006 80 : 5588 5598. (Pubitemid 43752805)
49. Baillie J, Sahlender DA, Sinclair JH. Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor. J Virol 2003 77 : 7007 7016. (Pubitemid 36666893)
50. Popkin DL, Virgin HWt. Murine cytomegalovirus infection inhibits tumor necrosis factor alpha responses in primary macrophages. J Virol 2003 77 : 10125 10130.
51. Le VT, Trilling M, Zimmermann A, Hengel H. Mouse cytomegalovirus inhibits beta interferon (IFN-beta) gene expression and controls activation pathways of the IFN-beta enhanceosome. J Gen Virol 2008 89 : 1131 1141.
52. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T, Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 1998 441 : 106 110. (Pubitemid 29012382)
53. Zimmermann A, Trilling M, Wagner M et al. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-gamma signaling and antiviral responses. J Exp Med 2005 201 : 1543 1553. (Pubitemid 40721000)
54. Marshall EE, Geballe AP. Multifaceted evasion of the interferon response by cytomegalovirus. J Interferon Cytokine Res 2009 29 : 609 619.
55. McCormick AL. Control of apoptosis by human cytomegalovirus. Curr Top Microbiol Immunol 2008 325 : 281 295.
56. Kalejta RF. Functions of human cytomegalovirus tegument proteins prior to immediate early gene expression. Curr Top Microbiol Immunol 2008 325 : 101 115.
57. Andoniou CE, Degli-Esposti MA. Insights into the mechanisms of CMV-mediated interference with cellular apoptosis. Immunol Cell Biol 2006 84 : 99 106.
58. Declercq W, Vanden Berghe T, Vandenabeele P. RIP kinases at the crossroads of cell death and survival. Cell 2009 138 : 229 232.
59. Mack C, Sickmann A, Lembo D, Brune W. Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci U S A 2008 105 : 3094 3099. (Pubitemid 351723673)
60. Upton JW, Kaiser WJ, Mocarski ES. Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem 2008 283 : 16966 16970.
61. Rebsamen M, Heinz LX, Meylan E et al. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep 2009 10 : 916 922.
62. Brune W, Menard C, Heesemann J, Koszinowski UH. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 2001 291 : 303 305. (Pubitemid 32096315)
63. Takaoka A, Wang Z, Choi MK et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007 448 : 501 505. (Pubitemid 47123520)
64. DeFilippis V, Alvarado D, Rothenburg S, Fruh K. Abstract (2.04): Human Cytomegalovirus Induces the Interferon Response via the DNA Receptor ZBP1.
65. Pyzik M, Kielczewska A, Vidal SM. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome. Semin Immunol 2008 20 : 331 342.
66. Scalzo AA, Yokoyama WM. Cmv1 and natural killer cell responses to murine cytomegalovirus infection. Curr Top Microbiol Immunol 2008 321 : 101 122.
67. Dalod M, Salazar-Mather TP, Malmgaard L et al. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 2002 195 : 517 528. (Pubitemid 34461304)
68. Dalod M, Hamilton T, Salomon R et al. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med 2003 197 : 885 898. (Pubitemid 36437865)
69. Krug A, French AR, Barchet W et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004 21 : 107 119. (Pubitemid 38925271)
70. Zucchini N, Bessou G, Robbins SH et al. Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection. Int Immunol 2008 20 : 45 56.
71. Akira S. TLR signaling. Curr Top Microbiol Immunol 2006 311 : 1 16. (Pubitemid 47413193)
72. Tabeta K, Georgel P, Janssen E et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 2004 101 : 3516 3521. (Pubitemid 38338227)
73. Andoniou CE, van Dommelen SL, Voigt V et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005 6 : 1011 1019. (Pubitemid 41486186)
74. Delale T, Paquin A, Asselin-Paturel C et al. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo. J Immunol 2005 175 : 6723 6732. (Pubitemid 41598916)
75. Zucchini N, Bessou G, Traub S et al. Cutting edge: overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J Immunol 2008 180 : 5799 5803.
76. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim YM. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 2007 177 : 265 275. (Pubitemid 46658638)
77. Tabeta K, Hoebe K, Janssen EM et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 2006 7 : 156 164. (Pubitemid 43135881)
78. Hoebe K, Du X, Georgel P et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003 424 : 743 748. (Pubitemid 37021696)
79. Hoebe K, Janssen EM, Kim SO et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 2003 4 : 1223 1229. (Pubitemid 37540691)
80. Szomolanyi-Tsuda E, Liang X, Welsh RM, Kurt-Jones EA, Finberg RW. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol 2006 80 : 4286 4291.
81. Barbalat R, Lau L, Locksley RM, Barton GM. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 2009 10 : 1200 1207.
82. Baccala R, Gonzalez-Quintial R, Lawson BR et al. Sensors of the innate immune system: their mode of action. Nat Rev Rheumatol 2009 5 : 448 456.
83. Salazar-Mather TP, Hokeness KL. Cytokine and chemokine networks: pathways to antiviral defense. Curr Top Microbiol Immunol 2006 303 : 29 46.
84. Hokeness-Antonelli KL, Crane MJ, Dragoi AM, Chu WM, Salazar-Mather TP. IFN-alphabeta-mediated inflammatory responses and antiviral defense in liver is TLR9-independent but MyD88-dependent during murine cytomegalovirus infection. J Immunol 2007 179 : 6176 6183.
85. Nguyen KB, Salazar-Mather TP, Dalod MY et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002 169 : 4279 4287.
86. Loh J, Chu DT, O'Guin AK, Yokoyama WM, Virgin HWt. Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol 2005 79 : 661 667. (Pubitemid 39648423)
87. Sumaria N, van Dommelen SL, Andoniou CE, Smyth MJ, Scalzo AA, Degli-Esposti MA. The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol Cell Biol 2009 87 : 559 566.
88. Tay CH, Welsh RM. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 1997 71 : 267 275.
89. Pien GC, Satoskar AR, Takeda K, Akira S, Biron CA. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J Immunol 2000 165 : 4787 4791.
90. Wesley JD, Tessmer MS, Chaukos D, Brossay L. NK cell-like behavior of Valpha14i NK T-cells during MCMV infection. PLoS Pathog 2008 4 : e1000106.
91. Cousens LP, Orange JS, Su HC, Biron CA. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci U S A 1997 94 : 634 639.
92. Jonjic S, Polic B, Krmpotic A. Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance? Eur J Immunol 2008 38 : 2952 2956.
93. Krmpotic A, Hasan M, Loewendorf A et al. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 2005 201 : 211 220. (Pubitemid 40189430)
94. Krmpotic A, Busch DH, Bubic I et al. MCMV glycoprotein gp40 confers virus resistance to CD8 + T-cells and NK cells in vivo. Nat Immunol 2002 3 : 529 535. (Pubitemid 34662304)
95. Lenac T, Budt M, Arapovic J et al. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med 2006 203 : 1843 1850. (Pubitemid 44188458)
96. Hasan M, Krmpotic A, Ruzsics Z et al. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol 2005 79 : 2920 2930. (Pubitemid 40270570)
97. Farrell HE, Vally H, Lynch DM et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997 386 : 510 514. (Pubitemid 27164079)
98. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002 296 : 1323 1326. (Pubitemid 34522789)
99. Arase H, Lanier LL. Virus-driven evolution of natural killer cell receptors. Microbes Infect 2002 4 : 1505 1512. (Pubitemid 36050819)
100. Kielczewska A, Pyzik M, Sun T et al. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med 2009 206 : 515 523.
101. Wilkinson GW, Tomasec P, Stanton RJ et al. Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 2008 41 : 206 212.
102. Sinclair J. Manipulation of dendritic cell functions by human cytomegalovirus. Expert Rev Mol Med 2008 10 : e35.
103. Raftery MJ, Schwab M, Eibert SM, Samstag Y, Walczak H, Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 2001 15 : 997 1009. (Pubitemid 34075379)
104. Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 2002 99 : 2913 2921. (Pubitemid 34525381)
105. Hertel L, Lacaille VG, Strobl H, Mellins ED, Mocarski ES. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol 2003 77 : 7563 7574. (Pubitemid 36734526)
106. Senechal B, Boruchov AM, Reagan JL, Hart DN, Young JW. Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 2004 103 : 4207 4215. (Pubitemid 38685365)
107. Beck K, Meyer-Konig U, Weidmann M, Nern C, Hufert FT. Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape. Eur J Immunol 2003 33 : 1528 1538. (Pubitemid 36790413)
108. Chang WL, Barry PA, Szubin R, Wang D, Baumgarth N. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 2009 390 : 330 337.
109. Kvale EO, Dalgaard J, Lund-Johansen F et al. CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood 2006 107 : 2022 2029. (Pubitemid 43289386)
110. Varani S, Cederarv M, Feld S et al. Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J Immunol 2007 179 : 7767 7776.
111. Cederarv M, Soderberg-Naucler C, Odeberg J. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity. Immunobiology 2009 214 : 331 341.
112. Schneider K, Meyer-Koenig U, Hufert FT. Human cytomegalovirus impairs the function of plasmacytoid dendritic cells in lymphoid organs. PLoS ONE 2008 3 : e3482.
113. Zuniga EI, Liou LY, Mack L, Mendoza M, Oldstone MB. Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections. Cell Host Microbe 2008 4 : 374 386.
114. Varani S, Frascaroli G, Landini MP, Soderberg-Naucler C. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflam-mation and autoimmunity. Rev Med Virol 2009 19 : 131 145.
115. Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004 5 : 971 974. (Pubitemid 41057712)
116. Robbins SH, Bessou G, Cornillon A et al. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog 2007 3 : e123. (Pubitemid 47359092)
117. Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol 2000 1 : 70 6.
118. Karp CL, Biron CA, Irani DN. Interferon beta in multiple sclerosis: is IL-12 suppression the key? Immunol Today 2000 21 : 24 8.
119. Bahl K, Kim SK, Calcagno C et al. IFN-induced attrition of CD8 T-cells in the presence or absence of cognate antigen during the early stages of viral infections. J Immunol 2006 176 : 4284 4295. (Pubitemid 44264408)
120. Peacock CD, Kim SK, Welsh RM. Attrition of virus-specific memory CD8+ T-cells during reconstitution of lymphopenic environments. J Immunol 2003 171 : 655 663.
121. McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, Welsh RM. Attrition of bystander CD8 T-cells during virus-induced T-cell and interferon responses. J Virol 2001 75 : 5965 5976.
122. van Dommelen SL, Sumaria N, Schreiber RD, Scalzo AA, Smyth MJ, Degli-Esposti MA. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 2006 25 : 835 848. (Pubitemid 46107286)
123. Lee SH, Kim KS, Fodil-Cornu N, Vidal SM, Biron CA. Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J Exp Med 2009 206 : 2235 2251.
124. Doherty PC, Allan JE. Anti-asialo GM1 eliminates both inflammatory process and cytotoxic T-cell function in the lymphocytic choriomeningitis adoptive transfer model. Cell Immunol 1987 107 : 1 7.
125. Kalinski P, Mailliard RB, Giermasz A et al. Natural killer-dendritic cell cross-talk in cancer immunotherapy. Expert Opin Biol Ther 2005 5 : 1303 1315. (Pubitemid 41503042)
126. Kelly JM, Darcy PK, Markby JL et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 2002 3 : 83 90. (Pubitemid 34065622)
127. Kelly JM, Takeda K, Darcy PK, Yagita H, Smyth MJ. A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. J Immunol 2002 168 : 4472 4479. (Pubitemid 34441349)
128. Mocikat R, Braumuller H, Gumy A et al. Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003 19 : 561 569. (Pubitemid 37311437)
129. Walzer T, Dalod M, Vivier E, Zitvogel L. Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin Biol Ther 2005 5 (Suppl. 1 S49 59. (Pubitemid 41243345)
130. Granucci F, Zanoni I, Pavelka N et al. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J Exp Med 2004 200 : 287 295. (Pubitemid 39031248)
131. Borg C, Jalil A, Laderach D et al. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004 104 : 3267 3275. (Pubitemid 39507145)
132. Gerosa F, Gobbi A, Zorzi P et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 2005 174 : 727 734. (Pubitemid 40094266)
133. Koka R, Burkett P, Chien M, Chai S, Boone DL, Ma A. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J Immunol 2004 173 : 3594 3598. (Pubitemid 39280717)
134. Ferlazzo G, Pack M, Thomas D et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 2004 101 : 16606 16611. (Pubitemid 39557760)
135. Brilot F, Strowig T, Munz C. NK cells interactions with dendritic cells shape innate and adaptive immunity. Front Biosci 2008 13 : 6443 6454.
136. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 2003 4 : 175 181. (Pubitemid 36193020)
137. Sun JC, Ma A, Lanier LL. Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection. J Immunol 2009 183 : 2911 2914.
138. Martin-Fontecha A, Thomsen LL, Brett S et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004 5 : 1260 1265. (Pubitemid 41057741)
139. Mailliard RB, Son YI, Redlinger R et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 2003 171 : 2366 2373. (Pubitemid 37025543)
140. Mailliard RB, Alber SM, Shen H et al. IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med 2005 202 : 941 953.
141. Cooper MA, Colonna M, Yokoyama WM. Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep 2009 10 : 1103 1110.
142. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S et al. Microbial flora drives interleukin 22 production in intestinal NKp46 + cells that provide innate mucosal immune defense. Immunity 2008 29 : 958 970.
143. Sanos SL, Bui VL, Mortha A et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 2009 10 : 83 91.
144. Cella M, Fuchs A, Vermi W et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009 457 : 722 725.
145. Cupedo T, Crellin NK, Papazian N et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009 10 : 66 74.
146. Andoniou CE, Coudert JD, Degli-Esposti MA. Killers and beyond: NK-cell-mediated control of immune responses. Eur J Immunol 2008 38 : 2938 2942.
147. Salazar-Mather TP, Lewis CA, Biron CA. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J Clin Invest 2002 110 : 321 330.
148. Crane MJ, Hokeness-Antonelli KL, Salazar-Mather TP. Regulation of inflammatory monocyte/macrophage recruitment from the bone marrow during murine cytomegalovirus infection: role for type I interferons in localized induction of CCR2 ligands. J Immunol 2009 183 : 2810 2817.
149. Hokeness KL, Deweerd ES, Munks MW, Lewis CA, Gladue RP, Salazar-Mather TP. CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection. J Virol 2007 81 : 1241 1250.
150. Beisser PS, Lavreysen H, Bruggeman CA, Vink C. Chemokines and chemokine receptors encoded by cytomegaloviruses. Curr Top Microbiol Immunol 2008 325 : 221 242.
151. Doom CM, Hill AB. MHC class I immune evasion in MCMV infection. Med Microbiol Immunol 2008 197 : 191 204.
152. Rolle A, Olweus J. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures. APMIS 2009 117 : 413 426.
153. Benedict CA, Janssen EM. Immunosuppression, learning from the masters. Expert Rev Clin Immunol 2007 3 : 659 662.
154. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2001 2 : 1077 1084. (Pubitemid 33069504)
155. Le BonA, Etchart N, Rossmann C et al. Cross-priming of CD8+ T-cells stimulated by virus-induced type I interferon. Nat Immunol 2003 4 : 1009 1015. (Pubitemid 37265922)
156. Benedict CA, Loewendorf A, Garcia Z, Blazar BR, Janssen EM. Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. J Immunol 2008 180 : 4836 4847.
157. Munks MW, Pinto AK, Doom CM, Hill AB. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol 2007 178 : 7235 7241.
158. Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009 19 : 47 56.
159. Karrer U, Sierro S, Wagner M et al. Memory inflation: continuous
160. Sylwester AW, Mitchell BL, Edgar JB et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T-cells dominate the memory compartments of exposed subjects. J Exp Med 2005 202 : 673 685.
161. Moss P, Khan N. CD8(+) T-cell immunity to cytomegalovirus. Hum Immunol 2004 65 : 456 464.
162. Pitcher CJ, Hagen SI, Walker JM et al. Development and homeostasis of T cell memory in rhesus macaque. J Immunol 2002 168 : 29 43.
163. Waller EC, Day E, Sissons JG, Wills MR. Dynamics of T cell memory in human cytomegalovirus infection. Med Microbiol Immunol 2008 197 : 83 96.
164. Holtappels R, Pahl-Seibert MF, Thomas D, Reddehase MJ. Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T-cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 2000 74 : 11495 11503. (Pubitemid 32222297)
165. Sierro S, Rothkopf R, Klenerman P. Evolution of diverse antiviral CD8+ T cell populations after murine cytomegalovirus infection. Eur J Immunol 2005 35 : 1113 1123. (Pubitemid 40542218)
166. Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol 2006 177 : 450 458. (Pubitemid 43939158)
167. Arens R, Wang P, Sidney J et al. Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J Immunol 2008 180 : 6472 6476.
168. Snyder CM, Loewendorf A, Bonnett EL, Croft M, Benedict CA, Hill AB. CD4+ T cell help has an epitope-dependent impact on CD8+ T cell memory inflation during murine cytomegalovirus infection. J Immunol 2009 183 : 3932 3941.
169. Snyder CM, Cho KS, Bonnett EL, van Dommelen S, Shellam GR, Hill AB. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T-cells. Immunity 2008 29 : 650 659.
170. Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NK. Murine model of cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 2008 325 : 315 331.
171. Mocarski ES, Courcelle CT. Cytomegaloviruses and Their Replication.
172. Yue Y, Barry PA. Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus. Adv Virus Res 2008 72 : 207 226.
173. Campbell AE, Cavanaugh VJ, Slater JS. The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol 2008 197 : 205 213.
174. Humphreys IR, de Trez C, Kinkade A, Benedict CA, Croft M, Ware CF. Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J Exp Med 2007 204 : 1217 1225. (Pubitemid 46798163)
175. Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med 1989 169 : 1199 1212. (Pubitemid 19104957)
176. Cheung AK, Gottlieb DJ, Plachter B et al. The role of the human cytomegalovirus UL111A gene in downregulating CD4+ T cell recognition of latently infected cells: implications for virus elimination during latency. Blood 2009 114 : 4128 4137.
177. Adler SP. Human CMV vaccine trials: what if CMV caused a rash? J Clin Virol 2008 41 : 231 236.